{
    "uniprot_canonical_ac": "A0A0G2JZH0-1",
    "uniprot_id": [
        {
            "id": "A0A0G2JZH0_RAT",
            "url": "https://www.uniprot.org/uniprot/A0A0G2JZH0_RAT",
            "type": "external"
        }
    ],
    "mass": 39873.0,
    "length": 341,
    "protein_name": "Calcium binding protein 39",
    "gene_name": "Cab39",
    "organism": "Rat",
    "refseq_name": "calcium-binding protein 39 isoform 2",
    "refseq_ac": [
        {
            "id": "NP_001388554",
            "url": "https://www.ncbi.nlm.nih.gov/protein/NP_001388554",
            "type": "external"
        }
    ],
    "gene_names_uniprotkb": "Cab39",
    "gene_names_refseq": "Cab39; MO25; MO25alpha",
    "protein_names_uniprotkb": "Calcium binding protein 39",
    "protein_names_refseq": "calcium-binding protein 39 isoform 2",
    "tax_id": 10116,
    "disease": "cancer (Disease Ontology:DOID:162); pancreatic cancer (Disease Ontology:DOID:1793); transient cerebral ischemia (Disease Ontology:DOID:224); hepatocellular carcinoma (Disease Ontology:DOID:684); hyperthyroidism (Disease Ontology:DOID:7998)",
    "pathway": " (rno:301574);  (R-RNO-380972);  (R-RNO-6798695)",
    "pathway_count": 3,
    "publication_count": 3,
    "publication_id_list": "15292028;18669938;24811174",
    "function": "Cab39 differentially interacts with WNK4 and SPAK/OSR1 to switch the classic two kinase cascade into a signal kinase transduction, [RefSeq, PubMed]; Component of a complex that binds and activates STK11/LKB1. In the complex, required to stabilize the interaction between CAB39/MO25 (CAB39/MO25alpha or CAB39L/MO25beta) and STK11/LKB1., [UniProtKB, UniProtKB, UniProtKB, UniProtKB]; Endurance training markedly increased skeletal muscle LKB1 and MO25 protein without increasing AMPKK activity., [RefSeq, PubMed]; Examine thyroid hormone effects on LKB1, MO25, phospho-AMPK, phospho-CREB, and PGC-1alpha in rat muscle., [RefSeq, PubMed]",
    "predicted_glycosites": 0,
    "predicted_n_glycosites": 0,
    "predicted_o_glycosites": 0,
    "mined_glycosites": 0,
    "mined_n_glycosites": 0,
    "mined_o_glycosites": 0,
    "reported_n_glycosites": 0,
    "reported_o_glycosites": 0,
    "reported_n_glycosites_with_glycan": 0,
    "reported_o_glycosites_with_glycan": 0,
    "total_reported_n_glycosites": 0,
    "total_reported_o_glycosites": 0,
    "total_n_glycosites": 0,
    "total_o_glycosites": 0,
    "reported_fully_resolved_glycans": 0,
    "reported_phosphosites": 0,
    "reported_mutagensis": 0,
    "reported_glycation": 0,
    "reported_snv": 0,
    "reported_interactions": 0,
    "missing_score": 10000,
    "biomarker_type": "",
    "glycan_count": 0,
    "disease_count": 5,
    "glyco_site_count": 0,
    "binding_glycan_count": 0,
    "secondary_ac_list": "",
    "ec_number_list": [],
    "go_molecular_function": "GO:0030295 protein kinase activator activity;GO:0019900 kinase binding;GO:0043539 protein serine/threonine kinase activator activity",
    "go_cellular_component": "GO:1902554 serine/threonine protein kinase complex;GO:0005737 cytoplasm;GO:0030018 Z disc;GO:0032991 protein-containing complex",
    "go_biological_process": "GO:0007165 signal transduction;GO:0035556 intracellular signal transduction;GO:0014823 response to activity;GO:0097066 response to thyroid hormone",
    "synthesized_glycan_count": 0,
    "record_id": "A0A0G2JZH0-1",
    "record_type": "protein",
    "filter_code": "0000000.0000111.100000.0000000000001000.00000.000"
}